Exosome-Reversed Chemoresistance to Cisplatin in Non-Small Lung Cancer Through Transferring miR-613

INTRODUCTION: Non-small lung cancer (NSCLC) is one of the most common malignant tumors in the world. Chemoresistance is the main reason of adverse effects leading to the death of patients; thus, it is important to discover the potential target of chemotherapeutic resistance. METHODS: The expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Delong, Meng, Debin, Niu, Rungui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481302/
https://www.ncbi.nlm.nih.gov/pubmed/32943930
http://dx.doi.org/10.2147/CMAR.S254310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481302/
https://www.ncbi.nlm.nih.gov/pubmed/32943930
http://dx.doi.org/10.2147/CMAR.S254310

Ejemplares similares